The Milk Thistle (Silybum marianum) Compound Silibinin Inhibits Cardiomyogenesis of Embryonic Stem Cells by Interfering with Angiotensin II Signaling
The milk thistle (Silybum marianum (L.) Gaertn.) compound silibinin may be an inhibitor of the angiotensin II type 1 (AT1) receptor which is expressed in differentiating embryonic stem (ES) cells and is involved in the regulation of cardiomyogenesis. In the present study, it was demonstrated that si...
Saved in:
Main Authors: | Enas Hussein Ali (Author), Fatemeh Sharifpanah (Author), Amer Taha (Author), Suk Ying Tsang (Author), Maria Wartenberg (Author), Heinrich Sauer (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of milk thistle (silybum marianum) on glucose and lipid metabolism
by: Yukina Nakagome, et al.
Published: (2012) -
The risk of milk thistle (<i>Silybum marianum</i>) drug interactions
by: A. S. Kazakov, et al.
Published: (2018) -
A Review on Pharmacological, Cultivation and Biotechnology Aspects of Milk Thistle (Silybum marianum (L.) Gaertn.)
by: N Qavami, et al.
Published: (2013) -
Determination of Seed and Oil Yield and Yield Components in Two Variety of Milk Thistle (Silybum marianum Gaetrn.) Based on Path Analysis and Regression
by: N Qavami, et al.
Published: (2012) -
Pharmacological and Pharmacognosticl Activity of Silybum marianum
by: Huda Khalil Al-Bazaz, et al.
Published: (2020)